RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GARASSINO MC
Collezione AOU Alessandria

Items : 5

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.

2024
ASL Cuneo 2
AOU Alessandria
ASL Città di Torino

Grosso F; Garassino MC; Ceresoli GL; Pasello G; Petraglia S; De Simone I; Cuppone F; Gauna R; Verderame F; Alabiso I; Dellepiane C; Biello F; Lo Russo G; Occhipinti M; Proto C; Mazzeo L; De Angelis AM; Torri V; Crivellari S; Delfanti S; Cerbone L;

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2022 May;17(5):661-674. doi: 10.1016/j.jtho.2021.12.015. Epub 2022 Feb 1.

2022
AOU Alessandria

Whisenant JG; Baena J; Cortellini A; Huang LC; Lo Russo G; Porcu L; Wong SK; Bestvina CM; Hellmann MD; Roca E; Rizvi H; Monnet I; Boudjemaa A; Rogado J; Pasello G; Leighl NB; Arrieta O; Aujayeb A; Batra U; Azzam AY; Unk M; Azab MA; Zhumagaliyeva AN; Gomez-Martin C; Blaquier JB; Geraedts E; Mountzios G; Serrano-Montero G; Reinmuth N; et alii...

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis. in JTO clinical and research reports / JTO Clin Res Rep. 2022 Aug;3(8):100335. doi: 10.1016/j.jtocrr.2022.100335. Epub 2022 May 20.

2022
AOU Alessandria

Bestvina CM; Whisenant JG; Torri V; Cortellini A; Wakelee H; Peters S; Roca E; De Toma A; Hirsch FR; Mamdani H; Halmos B; Arrieta O; Metivier AC; Fidler MJ; Rogado J; Presley CJ; Mascaux C; Genova C; Blaquier JB; Addeo A; Finocchiaro G; Khan H; Mazieres J; Morgillo F; Bar J; Aujayeb A; Mountzios G; Scotti V; Grosso F; et alii...

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6.

2021
AOU Alessandria

Pinto C; Zucali PA; Pagano M; Grosso F; Pasello G; Garassino MC; Tiseo M; Soto Parra H; Grossi F; Cappuzzo F; de Marinis F; Pedrazzoli P; Bonomi M; Gianoncelli L; Perrino M; Santoro A; Zanelli F; Bonelli C; Maconi A; Frega S; Gervasi E; Boni L; Ceresoli GL;

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. in The Lancet. Oncology / Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12.

2020
AOU Alessandria

Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; et alii...